Putting women’s health in the spotlight
Cambridge researchers are working to undo a longstanding male bias in health research, to help drive more effective healthcare for all.

How is it possible that a woman is fifty percent more likely to receive the wrong initial diagnosis for a heart attack than a man? Or that men who report pain to a doctor tend to be prescribed pain medication, but women are more likely to be given sedatives or antidepressants?
The historically male-dominated medical profession has driven a male bias in health research and care.
For centuries, many aspects of female biology were not discussed – and in some cultures this is still the case today. Women have been sidelined or excluded from research into health conditions and drug treatments, their fluctuating hormones thought to be too much of a complication to getting reliable results.
The result is an alarming lack of understanding of many women’s health conditions, the ways women experience illness and disease differently to men, and the differences in their response to treatments.
“Research that wasn’t designed with women in mind has contributed to a healthcare system that doesn’t meet women’s needs.”
Professor Amanda Sferruzzi-Perri, Department of Physiology, Development and Neuroscience and St. John’s College
Professor Amanda Sferruzzi-Perri says the waves of hormonal changes that happen throughout a woman’s reproductive years, which don't occur in men, affect the body's immune system, metabolic system, and cardiovascular and respiratory systems.
“Puberty, pregnancy, breastfeeding and menopause can all permanently alter the female body, and are associated with a range of female-specific health issues and benefits,” she says. “This leads to different rates of certain conditions in men and women, as well as differences in how these conditions are experienced. We can’t simply generalise medical treatment across the sexes.”
A new network of Cambridge experts, led by Sferruzzi-Perri, is trying to redress the balance.
Mental health

Professor Amy Milton in the Department of Psychology studies mental health conditions with the aim of developing a personalised approach for more effective treatments, grounded in a deeper mechanistic understanding of what causes an individual’s symptoms.

Professor Amy Milton
Professor Amy Milton
She notes that the prevalence of certain mental health disorders can differ significantly between sexes, with hormonal differences likely to play a role.
“Post traumatic stress disorder, PTSD, is about twice as common in women as it is in men – and we don’t understand why,” says Milton. “This is largely because it has only recently become a requirement to include both sexes in pre-clinical medical research.”
“There can be a big variation in symptoms between two patients with the same mental health diagnosis too,” she says. “This could be due to sex differences, or a range of other factors – but unless scientists include both males and females in their studies, they won’t know where those sex differences exist.”
“If it turns out that there are no sex differences for a particular mental health disorder, then we can confidently generalise treatments between males and females. But if differences do exist, it might mean that some therapies are more effective in one sex than the other.”
Milton says that effective treatment of PTSD can depend on being more aware of a woman’s fluctuating hormone levels – not ignoring them.
“Oestrogen and progesterone levels can make a difference to how well a person responds to exposure therapy. So in terms of the timing of PTSD therapy, if it's just about scheduling appointments at a specific point in the menstrual cycle then that's such an easy win,” she says.
“Just think how many other easy wins we might be missing out on because we haven’t been considering how female hormones influence the effectiveness of treatments.”
Professor Amy Milton, Department of Psychology and Downing College
Breastfeeding

Breastfeeding is a uniquely female biological process. Human milk provides the best source of nutritional, developmental and immune support for babies, and the World Health Organisation recommends breastfeeding for the first year of an infant’s life.
Yet breastfeeding difficulties are common, and despite its importance this is a greatly understudied area of women’s health.
Dr Alecia-Jane Twigger in the Departments of Biochemistry and Pharmacology says this is because breastfeeding has traditionally been seen as a natural process, where any difficulties must be solved by the individual, rather than by society.
“There’s a lot of bias in thinking that breastfeeding is easy. But I've talked to so many women who have done their absolute best, and they've had amazing support, but they’re just not able to do it,” says Twigger. “I’m trying to figure out why, and what we can do about it.”
At the Cambridge Lactation Lab, Twigger is dedicated to understanding the biology of human milk production. She’s found a way around the need to take invasive biopsies from lactating breasts, which could jeopardise breastfeeding.
“The key is to develop reliable models for studying lactation,” says Twigger, whose work is supported by a prestigious UKRI Future Leaders Fellowship. “I discovered that breast milk contains the very secretory cells responsible for producing milk. We can extract these and grow them into 3D structures called organoids.”

Dr Alecia-Jane Twigger
Dr Alecia-Jane Twigger
“I want to get these organoids to produce milk in the lab - like mini boobs - so I can explore key questions about human lactation.”
Dr Alecia-Jane Twigger, Departments of Biochemistry and Pharmacology
Through her CAMB MOM study Twigger is collecting breast milk samples from volunteers, to study the composition of milk and establish the organoid models. Her goal is to use them to better understand and address breastfeeding challenges, especially low milk supply.
She’ll look at the genetic underpinnings of the products being secreted in the milk, including proteins, fats and metabolites which influence the growth of the baby, to uncover which genes are essential for milk production.
She’ll also investigate another big question: whether medicines taken by a breastfeeding mother are passed to her baby in the milk.
“There’s currently a huge limitation in advising pregnant and breastfeeding women about what medicines they can take, because we can't include them in clinical trials. Our organoid model will let us test whether drugs taken by the mother are passed into the milk, and whether they could be harmful to the baby.”
For more information about the CAMB MOM study email cambmom@bioc.cam.ac.uk or visit the website.
Deep time perspective

Dr Emma Pomeroy, Associate Professor in the Evolution of Health, Diet and Disease in the Department of Archaeology, is turning to the past to shed light on how women’s health might be improved today.
As an archaeologist studying human bones dating from the present day back to 400,000 years ago, she’s gaining a long-term perspective on the origins of contemporary health issues.

Dr Emma Pomeroy. Credit Graeme Barker.
Dr Emma Pomeroy. Credit Graeme Barker.
“I want to understand which aspects of our health we might have the power to change, and which are so deeply embedded in our biology that they’re beyond our control.”
Professor Emma Pomeroy, Department of Archaeology and Newnham College
Pomeroy is using innovative methods to uncover evidence of key transitions in women's lives - such as puberty, the onset of menstruation, pregnancy, childbirth, and menopause – and wants to understand how these milestones intersect with broader aspects of health.
One area where historical insight may prove valuable is obstructed labour, a complication where the baby becomes stuck in the birth canal. The traditional narrative is that evolution has led to a tight fit between a baby’s head and the birth canal in the mother’s pelvis, due to the development of upright walking and larger brain size.
This has long been seen as unchangeable, but recent research suggests otherwise. For example, early-life nutrition can significantly influence pelvic development.
“By examining skeletal remains, we can see that girls who had access to a nutritious diet grew taller and developed larger pelvises - reducing the risk of obstructed labour,” she explains. “Preventing overnutrition is just as important: the rapid transition to obesity we’re seeing across many countries increases the likelihood of bigger babies, which can also heighten the risk of obstructed labour.”
Even menopause, once thought impossible to detect in bones, might be visible through changes in tooth cementum - layers that form annually like tree rings and whose width is reduced during periods of physiological stress. Within the tooth crown itself, disruption to the layers of enamel during growth can also tell us about periods of poor nutrition and health. Pomeroy is investigating how these methods might tell us more about the lives of our close evolutionary relatives, the Neanderthals.
“Accessing information about past lives can really help us understand women’s health today, particularly the major changes in women’s lives like menopause that have been largely ignored by society,” she says.
Time for change

Biological sex is a major factor in how the body responds to most drugs and vaccines. Men and women also feel and manage pain in different ways. Women are much more sensitive to heat stress than men, because their bodies store fat in different ways and regulate temperature differently. Infectious diseases can affect men and women in distinct ways. The list goes on.
Awareness of the male bias in health research is finally starting to drive change. And many aspects of female reproductive biology - key life processes – that have traditionally been largely ignored by research are gaining greater attention.
Research funders now ask scientists to take sex into account in their proposed cell and animal investigations where this might be relevant, or to justify why not. Pharmaceutical companies, too, want to know whether their drugs are safe to give to women, which means involving both sexes in clinical trials.

Professor Amanda Sferruzzi-Perri
Professor Amanda Sferruzzi-Perri
“It’s crazy that biological sex has been so overlooked in understanding the body’s responses to drugs and treatments.
It’s time we made a concerted effort to address this, and drive forward a personalised approach to improving human health.”
Professor Amanda Sferruzzi-Perri, Department of Physiology, Development and Neuroscience
Sferruzzi-Perri hopes that Cambridge's research focus on women’s health will help drive a vastly improved understanding, so that in future everyone receives the best quality health information and care.
Article published: 2 July 2025
Read more about Cambridge's Women's Health Network
Top image: Ryan McVay/GettyImages
The text in this work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
